Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COM PAR
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
244,636
-
Shares change
-
-677
-
Total reported value, excl. options
-
$1,923,000
-
Value change
-
-$5,066
-
Number of buys
-
3
-
Number of sells
-
-5
-
Price
-
$7.87
Significant Holders of IMMUCELL CORP /DE/ - COM PAR (ICCC) as of Q2 2015
10 filings reported holding ICCC - IMMUCELL CORP /DE/ - COM PAR as of Q2 2015.
IMMUCELL CORP /DE/ - COM PAR (ICCC) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 244,636 shares
.
Largest 10 shareholders include HealthInvest Partners AB (108,750 shares), SHUFRO ROSE & CO LLC (49,468 shares), RENAISSANCE TECHNOLOGIES LLC (27,700 shares), Essex Financial Services, Inc. (23,776 shares), GRT CAPITAL PARTNERS L.L.C. (19,704 shares), VANGUARD GROUP INC (10,075 shares), UBS Group AG (2,300 shares), BANK OF AMERICA CORP /DE/ (2,032 shares), Tower Research Capital LLC (TRC) (831 shares), and Creative Planning (0 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.